JM Financial initiates coverage on OneSource Specialty Pharma with a Buy call, target price Rs 2,049JM Financial initiates a Buy call on OneSource Specialty Pharma, setting a target price of Rs 2,049, driven by its unique CDMO positioning ...
05 May, 2025, 09.11 AM IST
Piramal Pharma deploying USD 85 mn capex this fiscal: Nandini PiramalPiramal Pharma is investing USD 85 million this fiscal for initiatives like capacity expansion and maintenance. They have already used USD ...
27 Oct, 2024, 11.48 AM IST
Piramal Pharma stock in focus on $80 million expansion plan for Kentucky injectables facilityPiramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet growing injectabl...
01 Oct, 2024, 09.53 AM IST
Jubilant Pharmova's US arm prepays Rs 626 crore term loanJubilant Pharmova's US subsidiary secured a $75 million term loan, as of March 31, 2024, the company's gross debt stood at Rs. 3,414 crore ...
25 Jun, 2024, 02.02 PM IST
Maiva Pharma raises Rs 1,000 cr from Morgan Stanley PE and India Life Sciences FundMaiva Pharma has raised Rs 1,000 crore from Morgan Stanley Private Equity Asia and India Life Sciences Fund, including both primary and sec...
02 May, 2024, 05.52 PM IST
Maiva Pharma raises Rs 1000 crore from Morgan Stanley Private Equity, InvAscentMorgan Stanley PE Asia and India Life Sciences Fund are investing almost equally, total stake with both funds combined will be over 60% pos...
02 May, 2024, 02.36 PM IST
Fundamental Radar: Why does Piramal Pharma stock deserve a re-rating? Sandeep Raina explainsThe company witnessed multiple challenges related to macroeconomic factors during and after COVID-19, high attrition at European manufactur...
27 Feb, 2024, 10.00 AM IST
Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businessesAs per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. T...
26 Sep, 2023, 12.17 PM IST
Strides Pharma to spin off CDMO assets to form a separate unitPharmaceutical company Strides Pharma is planning to demerge its contract development and manufacturing services (CDMO) assets into an asso...
26 Sep, 2023, 01.06 AM IST
Morgan Stanley offloads stake in this pharma stock via bulk dealMorgan Stanley Investment Funds Emerging Markets Equity Fund has sold a 0.58% stake in Gland Pharma via open market transactions. The sell-...
22 May, 2023, 08.17 PM IST
3 reasons Laurus Labs is this week's stock pickLaurus Labs will benefit from the growth prospects of the global and domestic pharma indutry as spending on medicines, including Covid-19 v...
27 Dec, 2022, 11.37 AM IST
Fosun taps big buyout funds for Gland PharmaBuyout firms Advent International, Baring Private Equity Asia (now owned by EQT), Bain Capital, Blackstone, Carlyle and KKR are among those...
14 Dec, 2022, 01.02 PM IST
Gland Pharma falls 5% after announcing Cenexi Group acquisitionCenexi, along with its subsidiaries, is engaged primarily in the business of Contract Development & Manufacturing Organisation (CDMO) of ph...
30 Nov, 2022, 01.26 PM IST
Gland Pharma acquires French CDMO Cenexi for €120 millionFounded in 2004, Cenexi, along with its subsidiaries, is engaged primarily in the business of CDMO of pharmaceutical products with expertis...
29 Nov, 2022, 06.23 PM IST
Smartkarma Research: APAC Healthcare Series - Top picks are poised for multi-year growthGland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...
03 Mar, 2022, 01.02 PM IST
PAG to acquire contact manufacturer Acme FormulationFounded in 2005 by Viral Shah, Acme provides contract development and manufacturing services to major Indian and global pharmaceutical comp...
22 Jul, 2021, 02.31 PM IST
Recipharm to take majority stake in Nitin Life for Rs 671 croreThe Sweden-based drug firm Recipharm has entered into an agreement to acquire a majority stake in Nitin Lifesciences Ltd.
20 Oct, 2015, 02.59 PM IST